Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 915

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 915
---
5 million was converted into 500,000 shares of Series A Preferred Stock at a conversion price of $1.00 per share pursuant to the terms of grant agreement, dated as of March 2018. The following tables summarize the Company’s redeemable convertible preferred stock as of December 31, 2023 and 2022:

| ​                        | ​ | ​ | Par Value |   |       |   | ​ | ​ | Preferred StockAuthorized |   |            |   | ​ | ​ | Preferred StockIssued andOutstanding |   |            |   | ​ | ​ | CarryingValue |   |        |   | ​ | ​ | LiquidationPreference |   |        |   | ​ | ​ | Common StockIssuable UponConversion |   |            |   | ​ |
|:-------------------------|:--|:--|:----------|:--|------:|:--|:--|:--|:--------------------------|:--|-----------:|:--|:--|:--|:-------------------------------------|:--|-----------:|:--|:--|:--|:--------------|:--|-------:|:--|:--|:--|:----------------------|:--|-------:|:--|:--|:--|:------------------------------------|:--|-----------:|:--|:--|
| Series A preferred stock | ​ | ​ | ​         | $ | 0.001 | ​ | ​ | ​ | ​                         | ​ |  9,499,999 | ​ | ​ | ​ | ​                                    | ​ |  9,499,999 | ​ | ​ | ​ | ​             | $ |  9,327 | ​ | ​ | ​ | ​                     | $ |  9,500 | ​ | ​ | ​ | ​                                   | ​ |  9,499,999 | ​ | ​ |
| Series B preferred stock | ​ | ​ | ​         | ​ | 0.001 | ​ | ​ | ​ | ​                         | ​ | 20,223,541 | ​ | ​ | ​ | ​                                    | ​ | 20,055,539 | ​ | ​ | ​ | ​             | ​ | 76,176 | ​ | ​ | ​ | ​                     | ​ | 76,402 | ​ | ​ | ​ | ​                                   | ​ | 20,055,539 | ​ | ​ |
| ​